Skip to main content
Edwards Lifesciences8-K: Product launch

FDA Approves PASCAL Precision for Tricuspid and PASCAL Ace with Capture Clarity

Source: Autobound Signal API · 68 signals tracked for Edwards Lifesciences · updated

Get Edwards Lifesciences' live signals in Claude or ChatGPT, or by API

AskWhat changed at Edwards Lifesciences this week? Use Autobound signals for edwards.com.

What happened

Edwards Lifesciences received U.S. FDA approval for the PASCAL Precision system for tricuspid regurgitation and PASCAL Ace with Capture Clarity for degenerative mitral TEER procedures, initiating measured rollouts.

Source

SEC EDGARNov 4, 2026

Current report (Form 8-K)

Edwards Lifesciences 8-K

Filing excerpt

In October, the FDA approved the PASCAL Precision system for tricuspid regurgitation, expanding access to this important therapy for patients.

sec.gov/Archives/edgar/data/1099800/000109980026000053/ew-20261104.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Product launch

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
11/04
Filed
Nov 4, 2026

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1099800
Accession number
0001099800-26-000053
Timeframe
Current quarter
Filing year
2026
Why it matters
Go-to-market support
Signal category
Strategic

Topics and mentions

Technologies

  • Capture Clarity

Regions named

  • U.S.

Extraction

Confidence
High
Relevance
80%
Sentiment
Positive
Detected
Nov 10, 2026
signal_type
sec-8k
signal_subtype
productLaunch

Use this data

Get every 8-K signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/9a2a46fa-f935-4715-afe2-2d4b68173a36 returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.

{
  "signal_id": "9a2a46fa-f935-4715-afe2-2d4b68173a36",
  "signal_type": "sec-8k",
  "signal_subtype": "productLaunch",
  "detected_at": "2026-11-10T07:04:15.822+00:00",
  "company": {
    "name": "Edwards Lifesciences",
    "domain": "edwards.com"
  },
  "data": {
    "detail": "Edwards Lifesciences received U.S. FDA approval for the PASCAL Precision system for tricuspid regurgitation and PASCAL Ace with Capture Clarity for degenerative mitral TEER procedures, initiating measured rollouts. This expansion in commercial therapies may drive demand for clinical training, commercial enablement, and specialized surgical and hospital-provider engagement tools.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "FDA Approves PASCAL Precision for Tricuspid and PASCAL Ace with Capture Clarity",
    "excerpts": "In October, the FDA approved the PASCAL Precision system for tricuspid regurgitation, expanding access to this important therapy for patients.",
    "relevance": 0.8,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000053/ew-20261104.htm",
    "filing_date": "2026-11-04",
    "filing_year": 2026,
    "fiscal_year_end": "11/04",
    "sales_relevance": "Go-to-market support",
    "signal_category": "strategic",
    "regions_mentioned": [
      "U.S."
    ],
    "technologies_mentioned": [
      "Capture Clarity"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.